TY - JOUR T1 - Abstract 3413: Dissecting the combination of gemcitabine and the Chk1 inhibitor MK-8776 in vitro and in vivo: cell cycle perturbation and the impact of administration schedule. JO - Cancer Research UR - http://dx.doi.org/10.1158/1538-7445.am2013-3413 PY - 2013/04/15 AU - Eastman A AU - Montano R AU - Thompson R AU - Khan N AU - Hou H AU - Lewis LD AU - Seigne JD AU - Ernstoff MS ED - DO - DOI: 10.1158/1538-7445.am2013-3413 PB - American Association for Cancer Research (AACR) VL - 73 IS - 8_Supplement SP - 3413 EP - 3413 Y2 - 2024/12/25 ER -